SEC Form 4 · accession 0001209191-18-010820
AtriCure, Inc. · ATRC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Justin J Noznesky
Officer — SVP, Mktg & Business Develop
Period of report
Feb 15, 2018
Accepted (ET)
Feb 16, 2018 · 4:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001323885
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 15, 2018 | S | 4,000 | $17.03 | D | 124,997 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were sold pursuant to a 10b5-1 trading plan.
- F2This transaction was executed in multiple trades at prices ranging from $16.62 to $17.40 per share. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.